Injectable semaglutide, administered once weekly, sidesteps these timing constraints and delivers steady levels throughout the week
Eloralintide Novos delays and the strategy behind them Lillys surprising phase 2 results (up to 20% weight loss) Combination therapies with tirzepatide or retatrutide 22:30 FDA Pipeline Acceleration Potential removal of traditional phase 3 trials How this speeds up the arrival of next-generation therapies 24:15 Oral GLP-1 Small Molecules (Structure Therapeutics) Alaniglipron data and the stock surge Comparisons to orforglipron and past failures like denuglipron Why Dave remains skeptical 28:40 Sponsor Break: Shed & Shapa Access, coaching, and patient support Using a numberless scale to build a healthier relationship with weight tracking 31:10 Counterfeit Ozempic Warning New fake lot discovered in U.S
FAQs Can I get a GLP-1 if I dont have diabetes
Harmonization at the WHO or ICMRA level could reduce per-program global regulatory cost by an estimated $30-50 million, which would materially improve viability for mid-revenue biologic targets
BMI remained higher in the GLP-1 group even after matching, so some residual differences between the groups stayed in
AGEs are final, permanent products of glycation that can modify the physicochemical properties of proteins, increase their resistance to proteolysis, and interact with RAGE receptors, causing oxidative stress and an inflammatory response 57
